Research advances in traditional Chinese medicine syndromes in cancer patients

Q Ji, Y Luo, W Wang, X Liu, Q Li, S Su - Journal of Integrative Medicine, 2016 - Elsevier
Traditional Chinese medicine (TCM) syndrome, also known as TCM ZHENG or TCM pattern,
is an integral and essential part of TCM theory that helps to guide the design of …

Engineered microenvironments provide new insights into ovarian and prostate cancer progression and drug responses

D Loessner, BM Holzapfel, JA Clements - Advanced drug delivery reviews, 2014 - Elsevier
Tissue engineering technologies, which have originally been designed to reconstitute
damaged tissue structure and function, can mimic not only tissue regeneration processes …

Development and validation of a novel 11-gene prognostic model for serous ovarian carcinomas based on lipid metabolism expression profile

M Zheng, H Mullikin, A Hester, B Czogalla… - International journal of …, 2020 - mdpi.com
(1) Background: Biomarkers might play a significant role in predicting the clinical outcomes
of patients with ovarian cancer. By analyzing lipid metabolism genes, future perspectives …

Stress-adaptive response in ovarian cancer drug resistance: role of TRAP1 in oxidative metabolism-driven inflammation

MR Amoroso, DS Matassa, I Agliarulo, R Avolio… - Advances in protein …, 2017 - Elsevier
Metabolic reprogramming is one of the most frequent stress-adaptive response of cancer
cells to survive environmental changes and meet increasing nutrient requirements during …

BRCA1 as a nicotinamide adenine dinucleotide (NAD)-dependent metabolic switch in ovarian cancer

D Li, NN Chen, JM Cao, WP Sun, YM Zhou, CY Li… - Cell cycle, 2014 - Taylor & Francis
Both hereditary factors (eg, BRCA1) and nicotinamide adenine dinucleotide (NAD)-
dependent metabolic pathways are implicated in the initiation and progression of ovarian …

A novel crosstalk between BRCA1 and sirtuin 1 in ovarian cancer

D Li, FF Bi, NN Chen, JM Cao, WP Sun, YM Zhou… - Scientific reports, 2014 - nature.com
BRCA mutations are the main known hereditary factors for ovarian cancer. Notably,
emerging evidence has led to considerable interest in the role of sirtuin 1 (SIRT1) in ovarian …

Identification of core genes in ovarian cancer by an integrative meta-analysis

W Li, Z Liu, B Liang, S Chen, X Zhang, X Tong… - Journal of Ovarian …, 2018 - Springer
Background Epithelial ovarian cancer is one of the most severe public health threats in
women. Since it is still challenging to screen in early stages, identification of core genes that …

[HTML][HTML] Poly (ADP-ribose) polymerase 1 transcriptional regulation: a novel crosstalk between histone modification H3K9ac and ETS1 motif hypomethylation in BRCA1 …

D Li, FF Bi, JM Cao, C Cao, CY Li, B Liu, Q Yang - Oncotarget, 2014 - ncbi.nlm.nih.gov
Abstract Poly (ADP-ribose) polymerase 1 (PARP1) plays a critical role in ovarian cancer
progression. However, the epigenetic mechanism regulating PARP1 transcription remains …

Constructing gene similarity networks using co-occurrence probabilities

G Mirzaei - BMC genomics, 2023 - Springer
Gene similarity networks play important role in unraveling the intricate associations within
diverse cancer types. Conventionally, gauging the similarity between genes has been …

[HTML][HTML] Nicotinamide adenine dinucleotide (NAD) may affect DNA methyltransferase 1 through regulation of BRCA1 in ovarian cancer

YY Fang, FF Bi, YM Zhou, WP Sun, CY Li… - American Journal of …, 2015 - ncbi.nlm.nih.gov
Nicotinamide adenine dinucleotide (NAD) is a crucial molecule of energy production and
signal transduction processes that have been linked to ovarian cancer development …